carcinoembryonic antigen


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to carcinoembryonic antigen: alpha fetoprotein

carcinoembryonic antigen

[¦kärs·ən·ō‚em·brē¦än·ik ′ant·i·jən]
(immunology)
A glycoprotein found in tissues of the fetal gut during the first two trimesters of pregnancy and in the peripheral blood of individuals with some forms of cancer, such as digestive-system or breast cancer.
References in periodicals archive ?
Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of antitumor immunity by allowing generation of immune effector / memory response.
Similarly, the association between persistently elevated carcinoembryonic antigen following colorectal surgery and resection of colorectal liver metastases has also been well documented (11, 12).
Pulmonary carcinoembryonic antigen (CEA) production in patients with end-stage lung diseases submitted to lung transplantation.
A reappraisal of the value of carcinoembryonic antigen in the management of patients with various neoplasms.
A blood test called Carcinoembryonic antigen (CEA) is often used to find out if the tumour is back or find how well it has responded to treatment.
In such cases, a second transvaginal ultrasound study was done and tumor markers were measured, including CA 125, CA 19-9, carcinoembryonic antigen, alpha-fetoprotein, and lactate dehydrogenase fraction.
These include prostate specific antigen (PSA), associated with prostate cancer, and carcinoembryonic antigen (CEA) which is found in 90 per cent of colon cancers and 40 per cent of breast cancers.
Patients with colorectal cancer are usually monitored by quantifying carcinoembryonic antigen (CEA) in serum in order to detect relapse earlier.
The serum carcinoembryonic antigen (CEA) and CA19-9 levels were normal; CA125 was 71.
In addition to targeting the carcinoembryonic antigen (CEA or CEACAM5) expressed by many human cancers, TF2 has been engineered to recognize a small peptide that carries radioactivity.
The serum levels of carcinoembryonic antigen and carbohydrate antigen 19-9 were within the normal reference range.